Literature DB >> 632272

Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis.

M J McDonald, R Shapiro, M Bleichman, J Solway, H F Bunn.   

Abstract

Human hemolysate contains several minor components designated Hb A1a, Hb A1b, Hb A1c, which are post-translational modifications of the major hemoglobin component A0. Individuals with diabetes mellitus have elevated levels of Hb A1c, a hemoglobin modified with a glucose moiety at the NH2 terminus of each beta chain. A new chromatographic technique using Bio-Rex 70 is described which not only allows complete separation of Hb A1a from Hb A1b but also resolution of Hb A1a into two components, designated Hb A1a1 and Hb A1a2. Carbohydrate determinations with the thiobarbituric acid procedure revealed that Hb A1a1, Hb A1a2, and Hb A1b as well as Hb A1c were glycosylated. Total phosphate analysis revealed 2.06 and 1.01 mol of phosphorus/alphabeta dimer for Hb A1a1 and Hb A1a2 respectively; Hb A1b and Hb A1c contained no detectable phosphate. Hemoglobin incubated with D-[14C]glucose-6-P co-chromatographs precisely with Hb A1a2, strongly suggesting that Hb A1a2 is glucose-6-P hemoglobin. Levels of Hb A1a1 and Hb A1a2 are normal in individuals with diabetes mellitus. Furthermore, diabetic red cells contain normal levels of glucose-6-P. Therefore, glucose-6-P hemoglobin does not serve as a significant precursor to Hb A1c. Instead Hb A1c is formed by the direct reaction of hemoglobin with glucose. This suggests that hemoglobin can serve as a model system for nonenzymatic glycosylation of protein.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 632272

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Glycated haemoglobin in the year 2000.

Authors:  E S Kilpatrick
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

2.  Fetal hemoglobin variants in 80,000 Japanese neonates: high prevalence of Hb F Yamaguchi (A gamma T 80 Asp----Asn).

Authors:  Y Wada; T Fujita; K Kidoguchi; A Hayashi
Journal:  Hum Genet       Date:  1986-03       Impact factor: 4.132

Review 3.  Haemoglobin A1 and diabetes mellitus.

Authors:  G Gonen; A H Rubenstein
Journal:  Diabetologia       Date:  1978-07       Impact factor: 10.122

4.  Amino-terminal processing of proteins: hemoglobin South Florida, a variant with retention of initiator methionine and N alpha-acetylation.

Authors:  J P Boissel; T J Kasper; S C Shah; J I Malone; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 5.  Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases.

Authors:  José D Méndez; Jianling Xie; Montserrat Aguilar-Hernández; Verna Méndez-Valenzuela
Journal:  Mol Cell Biochem       Date:  2010-07-31       Impact factor: 3.396

6.  Purification and characterization of testicular transferrin secreted by rat Sertoli cells.

Authors:  M K Skinner; W L Cosand; M D Griswold
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

7.  Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins.

Authors:  R L Garlick; J S Mazer; P J Higgins; H F Bunn
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

8.  Towards worldwide standardisation of HbA1c determination.

Authors:  K Miedema
Journal:  Diabetologia       Date:  2004-07-13       Impact factor: 10.122

9.  Separation of glycosylated haemoglobins using immobilized phenylboronic acid. Effect of ligand concentration, column operating conditions, and comparison with ion-exchange and isoelectric-focusing.

Authors:  F A Middle; A Bannister; A J Bellingham; P D Dean
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

Review 10.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Authors:  Qibin Zhang; Jennifer M Ames; Richard D Smith; John W Baynes; Thomas O Metz
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.